a successful course of chemotherapy ( myelosan or combined regimens ) results in a two to eight fold decrease of the percentage of s + g2 cells in the bone marrow and peripheral blood and in the restoration of normal morphometric and cytochemical patterns of polymorphonuclear neutrophils in the chronic phase of cgl .
C0005953
bone marrow
C0023474
chronic phase